Correlation Between NRBO Old and Unicycive Therapeutics

Can any of the company-specific risk be diversified away by investing in both NRBO Old and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRBO Old and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NRBO Old and Unicycive Therapeutics, you can compare the effects of market volatilities on NRBO Old and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRBO Old with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRBO Old and Unicycive Therapeutics.

Diversification Opportunities for NRBO Old and Unicycive Therapeutics

0.55

Correlation Coefficient

NRBO Old  Unicycive Therapeutics

Very weak diversification

The 3 months correlation between NRBO and Unicycive is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding NRBO Old and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and NRBO Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRBO Old are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of NRBO Old i.e., NRBO Old and Unicycive Therapeutics go up and down completely randomly.

Pair Corralation between NRBO Old and Unicycive Therapeutics

Given the investment horizon of 90 days NRBO Old is expected to generate 1.18 times more return on investment than Unicycive Therapeutics. However, NRBO Old is 1.18 times more volatile than Unicycive Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about -0.08 per unit of risk. If you would invest  198.00  in NRBO Old on December 30, 2024 and sell it today you would lose (9.00) from holding NRBO Old or give up 4.55% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	33.87%
Values	Daily Returns

NRBO Old  vs.  Unicycive Therapeutics

NRBO Old

Risk-Adjusted Performance

Very Weak

Over the last 90 days NRBO Old has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, NRBO Old is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Unicycive Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Unicycive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with NRBO Old and Unicycive Therapeutics

The main advantage of trading using opposite NRBO Old and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRBO Old position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.

The idea behind NRBO Old and Unicycive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.